| Trial ID: | L5637 |
| Source ID: | NCT00655200
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Safety profile of Insulin Detemir among Filipino patients, 3 months follow-up visit |
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
|
| Enrollment: |
2286
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-02
|
| Completion Date: |
2008-09
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-22
|
| Locations: |
Manilla, 1605, Philippines
|
| URL: |
https://clinicaltrials.gov/show/NCT00655200
|
